Roxane Laboratories

Red Exit sign

Pharma

Hikma cues 200 more layoffs as generics crunch continues

Hikma has already cut 200 jobs since picking up generics business Roxane Labs from Boehringer Ingelheim. But more layoffs are coming.

Carly Helfand Mar 16, 2018 11:16am

West-Ward Columbus

Hikma expands Ohio site it got in Roxane deal, adding 95 workers

Feb 1, 2017 12:40pm